chr12-110913109-A-C
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3_Moderate
The NM_000432.4(MYL2):c.389T>G(p.Phe130Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000432.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYL2 | NM_000432.4 | c.389T>G | p.Phe130Cys | missense_variant | Exon 6 of 7 | ENST00000228841.15 | NP_000423.2 | |
MYL2 | NM_001406745.1 | c.347T>G | p.Phe116Cys | missense_variant | Exon 5 of 6 | NP_001393674.1 | ||
MYL2 | NM_001406916.1 | c.332T>G | p.Phe111Cys | missense_variant | Exon 6 of 7 | NP_001393845.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYL2 | ENST00000228841.15 | c.389T>G | p.Phe130Cys | missense_variant | Exon 6 of 7 | 1 | NM_000432.4 | ENSP00000228841.8 | ||
MYL2 | ENST00000548438.1 | c.347T>G | p.Phe116Cys | missense_variant | Exon 5 of 6 | 3 | ENSP00000447154.1 | |||
MYL2 | ENST00000663220.1 | c.332T>G | p.Phe111Cys | missense_variant | Exon 6 of 7 | ENSP00000499568.1 | ||||
MYL2 | ENST00000549029.1 | n.*24T>G | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Phe130Cys variant in MYL2 has not been previously reported in individuals with cardiomyopathy or in large population studies. Phenylalanine (Phe) at posit ion 130 is highly conserved in mammals and across evolutionarily distant species and the change to Phenylalanine (Phe) was predicted to be pathogenic using a co mputational tool clinically validated by our laboratory. This tool's pathogenic prediction is estimated to be correct 94% of the time (Jordan 2011). In summary, the clinical significance of the p.Phe130Cys variant is uncertain. ACMG/AMP Cri teria applied: PM2; PP3. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at